Literature DB >> 18956290

The epidemiology of nonalcoholic fatty liver disease: a global perspective.

Mariana Lazo1, Jeanne M Clark.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is an increasingly recognized cause of liver disease in the United States and worldwide. With obesity being an important risk factor universally, NAFLD is now receiving greater attention and is regarded as a public health issue. In addition, as a result of an aging population and the improving control of other major causes of chronic liver disease, such as hepatitis C and hepatitis B, the burden of NAFLD is expected to increase in years to come. Prevalence estimates of this disease vary widely across populations because of differences in methods for diagnosis and/or definition. New strategies for the prevention, diagnosis, and management will be required to alter the course of this disease.

Entities:  

Mesh:

Year:  2008        PMID: 18956290     DOI: 10.1055/s-0028-1091978

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  263 in total

1.  Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease.

Authors:  Jody Dushay; Patricia C Chui; Gosala S Gopalakrishnan; Marta Varela-Rey; Meghan Crawley; Ffolliott M Fisher; Michael K Badman; Maria L Martinez-Chantar; Eleftheria Maratos-Flier
Journal:  Gastroenterology       Date:  2010-05-05       Impact factor: 22.682

2.  Genetic variation in the peroxisome proliferator activated receptor-gamma gene is associated with histologically advanced NAFLD.

Authors:  Samer Gawrieh; Miranda C Marion; Richard Komorowski; James Wallace; Michael Charlton; Ahmed Kissebah; Carl D Langefeld; Michael Olivier
Journal:  Dig Dis Sci       Date:  2011-12-09       Impact factor: 3.199

3.  A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis.

Authors:  Zobair M Younossi; Sandra Page; Nila Rafiq; Aybike Birerdinc; Maria Stepanova; Noreen Hossain; Arian Afendy; Zahra Younoszai; Zachary Goodman; Ancha Baranova
Journal:  Obes Surg       Date:  2011-04       Impact factor: 4.129

4.  Association of nonalcoholic fatty liver disease with low bone mass in postmenopausal women.

Authors:  Seong-Su Moon; Young-Sil Lee; Sung Woo Kim
Journal:  Endocrine       Date:  2012-03-11       Impact factor: 3.633

5.  Challenging the rodent hegemony: a new rabbit model of nonalcoholic steatohepatitis.

Authors:  Jaideep Behari; Naga Chalasani
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

6.  Hepatic gene networks in morbidly obese patients with nonalcoholic fatty liver disease.

Authors:  Samer Gawrieh; Tesfaye M Baye; Melanie Carless; James Wallace; Richard Komorowski; David E Kleiner; Deborah Andris; Bassem Makladi; Regina Cole; Michael Charlton; Joanne Curran; Thomas D Dyer; Jac Charlesworth; Russell Wilke; John Blangero; Ahmed H Kissebah; Michael Olivier
Journal:  Obes Surg       Date:  2010-12       Impact factor: 4.129

7.  Hepatic gene expression of Caucasian and African-American patients with obesity-related non-alcoholic fatty liver disease.

Authors:  Maria Stepanova; Noreen Hossain; Arian Afendy; Kellie Perry; Zachary D Goodman; Ancha Baranova; Zobair Younossi
Journal:  Obes Surg       Date:  2010-01-30       Impact factor: 4.129

8.  Nonalcoholic fatty liver disease: liver disease: an overlooked complication of diabetes mellitus.

Authors:  Marco Arrese
Journal:  Nat Rev Endocrinol       Date:  2010-12       Impact factor: 43.330

Review 9.  Epidemiology of NAFLD and Type 2 Diabetes: Health Disparities Among Persons of Hispanic Origin.

Authors:  Mariana Lazo; Usama Bilal; Rafael Perez-Escamilla
Journal:  Curr Diab Rep       Date:  2015-12       Impact factor: 4.810

Review 10.  Hepatocellular carcinoma: From clinical practice to evidence-based treatment protocols.

Authors:  Danijel Galun; Dragan Basaric; Marinko Zuvela; Predrag Bulajic; Aleksandar Bogdanovic; Nemanja Bidzic; Miroslav Milicevic
Journal:  World J Hepatol       Date:  2015-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.